These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6284334)
21. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736 [TBL] [Abstract][Full Text] [Related]
22. Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy. Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z Oncology; 1989; 46(2):105-8. PubMed ID: 2652018 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. McCabe M; Smith FP; Macdonald JS; Woolley PV; Goldberg D; Schein PS Invest New Drugs; 1988 Sep; 6(3):243-6. PubMed ID: 2847994 [TBL] [Abstract][Full Text] [Related]
24. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine]. Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905 [TBL] [Abstract][Full Text] [Related]
25. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159 [TBL] [Abstract][Full Text] [Related]
27. Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy. Friedman CJ; Burris HA; Yocom K; Blackburn LM; Gruben D Oncologist; 2000; 5(2):136-43. PubMed ID: 10794804 [TBL] [Abstract][Full Text] [Related]
28. Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial. Kleine-Brueggeney M; Greif R; Brenneisen R; Urwyler N; Stueber F; Theiler LG Anesth Analg; 2015 Nov; 121(5):1157-64. PubMed ID: 26426861 [TBL] [Abstract][Full Text] [Related]
29. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. Chan HS; Correia JA; MacLeod SM Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479 [TBL] [Abstract][Full Text] [Related]
30. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088 [TBL] [Abstract][Full Text] [Related]
31. Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy. Ungerleider JT; Andrysiak TA; Fairbanks LA; Tesler AS; Parker RG Radiology; 1984 Feb; 150(2):598-9. PubMed ID: 6318262 [TBL] [Abstract][Full Text] [Related]
32. Comparison of prochlorperazine and lorazepam antiemetic regimens in the control of postchemotherapy symptoms. Simms SG; Rhodes VA; Madsen RW Nurs Res; 1993; 42(4):234-9. PubMed ID: 8337162 [TBL] [Abstract][Full Text] [Related]
33. Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications. Levitt M; Wilson A; Bowman D; Kemel S; Krepart G; Marks V; Schipper H; Thomson G; Weinerman B; Weinerman R J Clin Pharmacol; 1981; 21(S1):103S-109S. PubMed ID: 6271814 [TBL] [Abstract][Full Text] [Related]
34. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy. Smaglia RA; Parkinson DR; Taylor CD Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417 [TBL] [Abstract][Full Text] [Related]
35. Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial. Collins RW; Jones JB; Walthall JD; Chisholm CD; Giles BK; Brizendine EJ; Cordell WH Ann Emerg Med; 2001 Nov; 38(5):491-6. PubMed ID: 11679859 [TBL] [Abstract][Full Text] [Related]
36. Review of cannabinoids and their antiemetic effectiveness. Vincent BJ; McQuiston DJ; Einhorn LH; Nagy CM; Brames MJ Drugs; 1983 Feb; 25 Suppl 1():52-62. PubMed ID: 6301800 [TBL] [Abstract][Full Text] [Related]
37. Comparative trial of the antiemetic effects of THC and haloperidol. Neidhart JA; Gagen MM; Wilson HE; Young DC J Clin Pharmacol; 1981; 21(S1):38S-42S. PubMed ID: 6271838 [TBL] [Abstract][Full Text] [Related]
38. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Rosenberg SA Cancer; 1981 Apr; 47(7):1746-51. PubMed ID: 6261926 [TBL] [Abstract][Full Text] [Related]
39. A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer. Silvey L; Carpenter JT; Wheeler RH; Lee J; Conolley C J Clin Oncol; 1988 Sep; 6(9):1397-400. PubMed ID: 3047334 [TBL] [Abstract][Full Text] [Related]
40. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study. Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]